TMS for Chronic and Neuropathic Pain: What the Evidence Shows

Is TMS approved for chronic or neuropathic pain?

Repetitive TMS is not FDA-cleared for chronic or neuropathic pain. TMS is FDA-cleared for major depressive disorder, as an adjunct for OCD, and to reduce anxiety symptoms in adults who have major depressive disorder. A separate single-pulse TMS device is cleared for migraine, which is a different use. Using repetitive TMS for chronic or neuropathic pain is off-label and investigational. This page is educational.

What the research shows

Research on repetitive TMS for pain reports mixed results, with some signal in specific conditions.

• A meta-analysis of high-frequency TMS over the dorsolateral prefrontal cortex found no overall effect across chronic pain conditions, but did find short-term relief in neuropathic pain specifically. The authors noted the evidence was limited and called for further study.
• European guidelines on neurostimulation gave a weak recommendation for TMS of the motor cortex in neuropathic pain and fibromyalgia, and rated prefrontal TMS as inconclusive, citing poor to moderate quality of evidence.

A weak recommendation and mixed findings are not the same as an established or approved treatment.

What this means if you have chronic pain

Chronic and neuropathic pain are managed by clinicians who specialize in pain, using approaches with stronger evidence. Repetitive TMS is not a standard treatment for these conditions. If you are exploring TMS for pain, do so only within a research setting or after a specialist has reviewed the limited evidence with you.

When TMS may be relevant

Chronic pain and depression often occur together. Depression is an FDA-cleared use of TMS. If you have major depressive disorder, TMS may be considered for the depression, evaluated on its own, not as a pain treatment. A clinical evaluation clarifies the diagnosis and the appropriate options.

TMS at Exxceed Wellness

We provide TMS for adults with treatment-resistant depression in Hayward, CA. We do not present TMS as a treatment for chronic or neuropathic pain. See our TMS program, our guide to treatment-resistant depression, or contact us.

Frequently asked questions

What does the research show about TMS for chronic pain?

Repetitive TMS has been studied for neuropathic pain and is not FDA-cleared for that use in the United States. Findings vary by protocol and target, and the evidence is not sufficient to establish it as a standard treatment for chronic or neuropathic pain.

Can TMS treat neuropathic pain?

Repetitive TMS is not FDA-cleared for neuropathic pain. Some studies show short-term relief, but overall evidence is mixed and guidelines rate it weak.

Is TMS approved for any pain condition?

A single-pulse TMS device is cleared for migraine. That is a separate device and use from repetitive TMS for chronic or neuropathic pain.

References

Based on research indexed in PubMed:

1. Che X, et al. High-frequency rTMS over the dorsolateral prefrontal cortex on chronic and provoked pain: A systematic review and meta-analysis. Brain Stimul. 2021;14(5):1135-1146. DOI.
2. Cruccu G, et al. EAN guidelines on central neurostimulation therapy in chronic pain conditions. Eur J Neurol. 2016;23(10):1489-1499. DOI.
3. U.S. FDA milestones for TMS devices: PMC.

Educational information only, not medical advice. TMS is FDA-cleared for major depressive disorder, as an adjunct for OCD, and to reduce anxiety symptoms in adults with major depressive disorder. Repetitive TMS is not FDA-cleared for chronic or neuropathic pain, and any such use is off-label and investigational. Outcomes vary, and candidacy is determined by a qualified clinician. Consult a clinician about your specific situation.

Care at Exxceed Wellness — Hayward, CA & California telehealth. We deliver FDA-cleared TMS on the Magstim Horizon 3.0 — for treatment-resistant depression, adult OCD, and adolescents 15–21 (depression, as an add-on to medication). Learn more ›, schedule a consultation, or call (415) 636-9700.